Kingdom, a developer of natural functional ingredients, has secured $25.0 million in new investment capital. This funding round marks a significant milestone for the company as it continues to advance its proprietary SupercultureĀ® ingredients, which are designed to address unmet health needs in both pet and human markets. The investment reflects strong confidence from investors in Kingdom's innovative approach and its clinically validated product pipeline.
Kingdom specializes in creating SupercultureĀ® ingredients, an entirely new class of clinically-validated postbiotics. These ingredients are engineered to target the root causes of various health issues. Currently, Kingdom offers SupercultureĀ® Pet Oral and SupercultureĀ® Pet Immune, its first two breakthrough ingredients that have demonstrated industry-leading efficacy and enable new marketing claims for brands. The company is committed to rigorous scientific validation, planning to complete 10 clinical studies on its SupercultureĀ® ingredients by the end of 2025, providing unparalleled validation in the market.
As a trusted ingredient partner, Kingdom works with top brands, integrating its SupercultureĀ® Pet Oral and SupercultureĀ® Pet Immune into their end products, with many more launches anticipated. Beyond pet health, Kingdom is also developing its first human SupercultureĀ® ingredient, signaling its intent to expand into broader wellness sectors. This capital infusion will be instrumental in accelerating the development of these new ingredients, expanding clinical research, and scaling production capabilities to meet growing demand.
The $25.0 million investment will primarily be used to fuel Kingdom's growth initiatives. This includes enhancing its research and development efforts to broaden the SupercultureĀ® ingredient portfolio, strengthening its market penetration, and supporting its strategic partnerships with leading brands. The company aims to further solidify its position as a leader in the functional ingredient space, continuing to deliver innovative, science-backed solutions for improved health outcomes.
.png&w=3840&q=75)
